Petros Pharmaceuticals Stock Analysis

Petros Stock Analysis Notes

The company has price-to-book ratio of 0.83. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Petros Pharmaceuticals recorded a loss per share of 3.8. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 1st of December 2022. Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on mens health therapeutics. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about Petros Pharmaceuticals contact the company at 973 242 0005 or learn more at https://www.petrospharma.com.

Petros Pharmaceuticals Investment Alerts

Petros Pharmaceuticals Upcoming and Recent Events

Petros Largest EPS Surprises

View All Earnings Estimates

Petros Stock Institutional Investors

Note, although Petros Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Petros Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.57 M.

Petros Profitablity

The company has Profit Margin (PM) of (1.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.6.

Management Efficiency

Petros Pharmaceuticals has return on total asset (ROA) of (0.3061) % which means that it has lost $0.3061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6377) %, meaning that it created substantial loss on money invested by shareholders. Petros Pharmaceuticals' management efficiency ratios could be used to measure how well Petros Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.35. The current Return On Capital Employed is estimated to decrease to -0.62. As of now, Petros Pharmaceuticals' Non Current Assets Total are decreasing as compared to previous years. The Petros Pharmaceuticals' current Non Currrent Assets Other is estimated to increase to about 6.2 M, while Other Assets are projected to decrease to under 9.4 M.

Technical Drivers

As of the 22nd of November, Petros Pharmaceuticals holds the Risk Adjusted Performance of (0.03), variance of 36.9, and Coefficient Of Variation of (2,169). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Petros Pharmaceuticals, as well as the relationship between them.

Petros Pharmaceuticals Price Movement Analysis

Petros Pharmaceuticals Insider Trading Activities

Petros Pharmaceuticals Outstanding Bonds

Petros Pharmaceuticals Predictive Daily Indicators

Petros Pharmaceuticals Forecast Models

Petros Pharmaceuticals' time-series forecasting models are one of many Petros Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Petros Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Petros Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Petros shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Petros Pharmaceuticals. By using and applying Petros Stock analysis, traders can create a robust methodology for identifying Petros entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Petros analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Petros analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Petros Pharmaceuticals stock analysis indicators help investors evaluate how Petros Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Petros Pharmaceuticals shares will generate the highest return on investment. By understating and applying Petros Pharmaceuticals stock analysis, traders can identify Petros Pharmaceuticals position entry and exit signals to maximize returns.

When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.